Ethicon, Inc.’s Post

https://lnkd.in/eaXBKZ9p.. The FDA just approved Ozempic for kidney disease Ozempic was found to reduce the combined risk of major kidney complications by 24% in patients with type 2 diabetes and chronic kidney disease

🌟 Diabetic Eye Disease Awareness: Protect Your Vision 🌟 Did you know that diabetic eye diseases, like diabetic retinopathy, are among the leading causes of vision loss worldwide? Early detection and regular eye exams can make all the difference in preserving your sight. Let’s spread the word about the importance of proactive eye care for people with diabetes. Together, we can promote education, encourage screenings, and protect vision for a brighter future. 🔍 Take Action: Schedule your comprehensive eye exam today! #DiabeticEyeDiseaseAwareness #EyeHealth #DiabetesCare #VisionMatters #lxbiopharmaceuticals

🦷 Periodontal Disease and Diabetes: A Closer Look 💻 Join us for a one-hour live webinar on 11/15 from noon to 1:00: Diabetes and Oral Health: Identifying, Preventing and Managing Common Oral Conditions. Learn: - the common oral conditions associated with diabetes; - the etiology, clinical appearance, and treatment options for common oral manifestations associated with diabetes; - the bidirectional relationship between diabetes and periodontal disease; - prevention and management strategies for patients with diabetes to reduce the risk and occurrence of oral complications. #OralHealth #Diabetes #PeriodontalPrevention #DiabetesDentalCare #OralCareStrategies

Understanding Crohn’s Disease: In the U.S., an estimated 3.1 million people have Crohn's disease, an inflammatory bowel disease that causes chronic inflammation of the gastrointestinal tract. Up to 80% of people with Crohn's disease will be hospitalized at some point in their life, per the CDC, with the disease most likely to develop between the ages of 20 & 29. Symptoms of Crohn’s may include: 🩺 Abdominal pain or cramps 🩺 Chronic diarrhea 🩺 Loss of appetite 🩺 Weight loss 🩺 Bloody stool 🩺 Mouth ulcers or pain in your mouth and gums 🩺 Fever & fatigue Unfortunately, there isn’t a cure for Crohn’s disease. Flare-ups are unpredictable and can disrupt your daily life. That’s why it’s important to talk to your healthcare provider about the steps you can take to keep the disease in check and help with your long-term health. For more on Crohn’s disease, check out our latest South Texas Health Minute on ValleyCentral.com. bit.ly/4fbg5fQ

#EASD24 Highlighting the importance of accurate cardiovascular risk assessment in type 2 diabetes! The SCORE2-Diabetes tool provides a personalized 10-year cardiovascular risk estimate for individuals with type 2 diabetes, enabling earlier intervention and more effective disease management. This Europe-specific tool helps clinicians make more accurate assessments, leading to better outcomes for patients with diabetes. European Association for the Study of Diabetes e.V. (EASD) Baruch Itzhak

In December, we recognize Crohn’s and Colitis Awareness Week, which is dedicated to raising awareness about these challenging digestive conditions. Crohn’s disease and ulcerative colitis are types of inflammatory bowel disease (IBD) that can cause severe digestive symptoms and impact daily life. At #ContinuumRx, we provide personalized antibiotic therapy to help manage symptoms and offer comfort with at-home treatments. Visit their website to learn more and support the IBD community: https://bit.ly/2SWPTxM #chronsanscolitis #CrohnsDiseaseAwareness #InfusionTherapy #HomeIntravenousAntibioticTherapy #Gastrointestinaldisorder #crohnsdisease #crohnsandcolitisawareness

#HidradenitisSuppurativa is a chronic, painful skin disease whereby there remains a tremendous need for new treatment options for patients, and for #HSAwarenessWeek we hope to increase awareness and understanding for this debilitating disease. We’re driven to revolutionize the treatment of immuno-inflammatory diseases by building an industry leading pipeline of oral medicines - learn more about #KT474, currently in Phase 2 trials for HS and AD: https://bit.ly/3KCXz2Z #RevolutionizingImmunology

Novo Nordisk’s Ozempic has secured a new FDA approval, expanding the GLP-1 blockbuster’s use to reduce the risk of kidney disease in patients with diabetes and chronic kidney disease (CKD). Read more at https://buff.ly/40Qbgon by Ayesha Rashid about the approval.

Discover Inflammatix's groundbreaking TriVerity™ Acute Infection and Sepsis Test, set to revolutionize sepsis diagnostics. Utilizing the Myrna instrument, this test assesses immune responses, delivering highly accurate insights into infection type and severity. This cutting-edge technology offers the potential for faster, more precise diagnoses, enhancing clinical care for patients with sepsis. Watch the video for more details on how this system works and its future impact. *The TriVerity™ Acute Infection & Sepsis Test System is not for sale. It is currently pending FDA clearance and has not received marketing approval or clearance from regulatory authorities in any jurisdiction. Inflammatix, Inc. Tim Sweeney #SepsisDiagnostics #MedicalInnovation #InfectionControl #CLINICAL24

Test for sore throat cuts antibiotic use by nearly a third! Did you know sore throats account for at least 1 in 4 GP appointments related to respiratory tract infections? 😷 A clinical scoring test developed by #NIHRfunded researchers has cut the use of antibiotics prescribed for sore throats by nearly a third. This is helping to reduce costs AND tackle antibiotic resistance. #NIHRsupporter #NIHRMakingaDifference